About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Side effect(s) of Azilsartan medoxomil

Read the side effects of Azilsartan medoxomil as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Most Common - Low blood pressure.

Gastrointestinal - Nausea.

General - Weakness and fatigue.

Musculoskeletal - Muscle spasm.

Central Nervous System - Dizziness.

Respiratory - Cough.



Other Precautions : * Avoid excess dosage.

Drug Name : Azilsartan medoxomil

Azilsartan medoxomil(Edarbi) generic is an angiotensin II receptor antagonist, prescribed for hypertension. It improves blood flow by widening blood vessels.
More Info about Azilsartan medoxomil

Trade Names for Azilsartan medoxomil

India : 

International : 

Edarbi
Advertisement



Advertisement
Recommended Reading
Drugs A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs Search


    Advertisement
    Drug Price
    ABEL (40mg)

    Lupin Laboratories Ltd.
    ABEL (80mg)

    Lupin Laboratories Ltd.
    What's New on Medindia
    Are Menopause Symptoms Troubling You?: Try these Options
    Vaccination  And Counter  Measures Against  Monkeypox
    Indian Railways Special Concession on Health Grounds
    View all

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    Selfie Addiction Calculator Loram (2 mg) (Lorazepam) Iron Intake Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Calculate Ideal Weight for Infants Sanatogen Vent Forte (Theophylline) Hearing Loss Calculator Diaphragmatic Hernia A-Z Drug Brands in India

    Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

    © All Rights Reserved 1997 - 2022

    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use